Clinical ResearchAug 12, 2026
Multidisciplinary Oncology
Why we add chemotherapy after surgery, the trap of assuming a gentler agent is safer, and KEYNOTE-689 finally bringing immunotherapy into the perioperative window.
Read the email
Why we add chemotherapy after surgery, the trap of assuming a gentler agent is safer, and KEYNOTE-689 finally bringing immunotherapy into the perioperative window.
Read the email